Oncolytic viruses for the treatment of adenoid cystic carcinoma
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2211079
- Recipient
-
University Of Miami UEI F8THLJQSAF93 Part of University Of Miami
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $537,250
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Miami, FL 33136, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $537,250 Project Grant to the University of Miami under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research on oncolytic viruses for the treatment of adenoid cystic carcinoma. The three-year award beginning September 15, 2022 will fund the development of medical solutions using oncolytic viruses, a type of virus that selectively infects and kills cancer cells. As part of the Military Medical Research and Development program's mission to transform military and public health through innovative medical research solutions, this award supports the University of Miami's work investigating new treatment approaches for adenoid cystic carcinoma through applied biomedical research techniques.
Quick answers
Who received award W81XWH2211079?
W81XWH2211079 was awarded to University Of Miami by Medical Command (Department of the Army) on September 15, 2022.
How much is award W81XWH2211079 worth?
$537,250 has been obligated on W81XWH2211079.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award